<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39171285</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-5588</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Chinese medical journal pulmonary and critical care medicine</Title><ISOAbbreviation>Chin Med J Pulm Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Mechanisms of long COVID: An updated review.</ArticleTitle><Pagination><StartPage>231</StartPage><EndPage>240</EndPage><MedlinePgn>231-240</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pccm.2023.10.003</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic has been ongoing for more than 3 years, with an enormous impact on global health and economies. In some patients, symptoms and signs may remain after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which cannot be explained by an alternate diagnosis; this condition has been defined as long COVID. Long COVID may exist in patients with both mild and severe disease and is prevalent after infection with different SARS-CoV-2 variants. The most common symptoms include fatigue, dyspnea, and other symptoms involving multiple organs. Vaccination results in lower rates of long COVID. To date, the mechanisms of long COVID remain unclear. In this narrative review, we summarized the clinical presentations and current evidence regarding the pathogenesis of long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xiaoying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiuyang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Chin Med J Pulm Crit Care Med</MedlineTA><NlmUniqueID>9918627881206676</NlmUniqueID><ISSNLinking>2772-5588</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiotensin-converting enzyme 2</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>22</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>22</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>22</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39171285</ArticleId><ArticleId IdType="pmc">PMC11332859</ArticleId><ArticleId IdType="doi">10.1016/j.pccm.2023.10.003</ArticleId><ArticleId IdType="pii">S2772-5588(23)00058-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence: Clinical Guidelines. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE 2020, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129. doi: 10.1016/s2213-2600(21)00031-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(21)00031-x</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer L. Lots of Long COVID treatment leads, but few are proven. Proc Natl Acad Sci U S A. 2022;119 doi: 10.1073/pnas.2213524119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2213524119</ArticleId><ArticleId IdType="pmc">PMC9456722</ArticleId><ArticleId IdType="pubmed">36048910</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, et al. Epidemiology and organ specific sequelae of post-acute COVID-19: a narrative review. J Infect. 2021;83:1&#x2013;16. doi: 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023;401:e21&#x2013;e23. doi: 10.1016/S0140-6736(23)00810-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/s0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378 doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpelli S, De Santis A, Alfonsi V, et al. The role of sleep and dreams in long-COVID. J Sleep Res. 2023;32:e13789. doi: 10.1111/jsr.13789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.13789</ArticleId><ArticleId IdType="pubmed">36398720</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10:863&#x2013;876. doi: 10.1016/s2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liao X, Liu Z, et al. Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study. Emerg Microbes Infect. 2022;11:2680&#x2013;2688. doi: 10.1080/22221751.2022.2133639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2133639</ArticleId><ArticleId IdType="pmc">PMC9639507</ArticleId><ArticleId IdType="pubmed">36215047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, ; Lifelines Corona Research Initiative Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/s0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Yang D, et al. Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization. J Neurol Sci. 2022;443 doi: 10.1016/j.jns.2022.120487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120487</ArticleId><ArticleId IdType="pmc">PMC9637014</ArticleId><ArticleId IdType="pubmed">36379135</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Dam Nielsen S, Nygaard U, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022;6:240&#x2013;248. doi: 10.1016/s2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona V, Kirouchena D, Clerc P, Pinsard-Laventure F, Bourrion B. Quality of life in COVID-19 outpatients: a long-term follow-up study. J Clin Med. 2022;11:6478. doi: 10.3390/jcm11216478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11216478</ArticleId><ArticleId IdType="pmc">PMC9657247</ArticleId><ArticleId IdType="pubmed">36362706</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinicci M, Graziani L, Tilli M, et al. Infection with SARS-CoV-2 variants is associated with different long COVID phenotypes. Viruses. 2022;14:2367. doi: 10.3390/v14112367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112367</ArticleId><ArticleId IdType="pmc">PMC9698829</ArticleId><ArticleId IdType="pubmed">36366465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Cancela-Cilleruelo I, Rodr&#xed;guez-Jim&#xe9;nez J, et al. Associated-onset symptoms and post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with Wuhan, alpha or delta SARS-CoV-2 variant. Pathogens. 2022;11:725. doi: 10.3390/pathogens11070725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Suzuki M, et al. Post COVID-19 condition of the omicron variant of SARS-CoV-2. J Infect Chemother. 2022;28:1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. COVID-19: long COVID risk is lower with omicron than delta, researchers find. BMJ. 2022;377:o1500. doi: 10.1136/bmj.o1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/s0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell'Isola A, et al. Post-COVID medical complaints following infection with SARS-CoV-2 omicron vs delta variants. Nat Commun. 2022;13:7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V, Yelin D, Awwad M, et al. Characteristics of long COVID among older adults: a cross-sectional study. Int J Infect Dis. 2022;125:287&#x2013;293. doi: 10.1016/j.ijid.2022.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.035</ArticleId><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6:230&#x2013;239. doi: 10.1016/s2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Skyrud KD, Suren P, et al. Healthcare use in 700 000 children and adolescents for six months after COVID-19: before and after register based cohort study. BMJ. 2022;376 doi: 10.1136/bmj-2021-066809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066809</ArticleId><ArticleId IdType="pmc">PMC8762452</ArticleId><ArticleId IdType="pubmed">35039315</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children &#x2013; a nationwide cohort study. Eur J Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rytter MJH. Difficult questions about long COVID in children. Lancet Child Adolesc Health. 2022;6:595&#x2013;597. doi: 10.1016/s2352-4642(22)00167-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00167-5</ArticleId><ArticleId IdType="pmc">PMC9221929</ArticleId><ArticleId IdType="pubmed">35752193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Bull-Otterson L, Boehmer TK, et al. Post-COVID-19 symptoms and conditions among children and adolescents &#x2013; United States, March 1, 2020-January 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:993&#x2013;999. doi: 10.15585/mmwr.mm7131a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7131a3</ArticleId><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19 doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczborska K, Buda P, Ksi&#x105;&#x17c;yk J. Long-COVID in immunocompromised children. Eur J Pediatr. 2022;181:3501&#x2013;3509. doi: 10.1007/s00431-022-04561-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04561-1</ArticleId><ArticleId IdType="pmc">PMC9281224</ArticleId><ArticleId IdType="pubmed">35834042</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunvoll SH, Nygaard AB, Fagerland MW, et al. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection. Int J Infect Dis. 2023;126:10&#x2013;13. doi: 10.1016/j.ijid.2022.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.11.009</ArticleId><ArticleId IdType="pmc">PMC9651990</ArticleId><ArticleId IdType="pubmed">36375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, De Martino M, Palese A, et al. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect. 2022;28:1140&#x2013;1148. doi: 10.1016/j.cmi.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="pubmed">35339673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Baraff A, Fox A, et al. Rates and factors associated with documentation of diagnostic codes for long COVID in the national veterans affairs health care system. JAMA Netw Open. 2022;5 doi: 10.1001/jamanetworkopen.2022.24359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.24359</ArticleId><ArticleId IdType="pmc">PMC9338411</ArticleId><ArticleId IdType="pubmed">35904783</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Metaxaki M, Wills MR, Sithole N. Reduced incidence of long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic. Clin Infect Dis. 2023;76:738&#x2013;740. doi: 10.1093/cid/ciac630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac630</ArticleId><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, et al. Impact of pre-existing chronic viral infection and reactivation on the development of Long COVID. J Clin Invest. 2022 doi: 10.1172/jci163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci163669</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Wang G, Wang Y, et al. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. Lancet Microbe. 2022;3:e348&#x2013;e356. doi: 10.1016/s2666-5247(22)00036-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-5247(22)00036-2</ArticleId><ArticleId IdType="pmc">PMC8942480</ArticleId><ArticleId IdType="pubmed">35345417</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundura L, Cezar R, Andr&#xe9; S, et al. Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.1029006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1029006</ArticleId><ArticleId IdType="pmc">PMC9630742</ArticleId><ArticleId IdType="pubmed">36341327</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, et al. Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M, Vig&#xf3;n L, Fuertes D, et al. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjelltveit EB, Blomberg B, Kuwelker K, et al. Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study. Clin Infect Dis. 2023;76:e60&#x2013;e70. doi: 10.1093/cid/ciac655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac655</ArticleId><ArticleId IdType="pmc">PMC9384725</ArticleId><ArticleId IdType="pubmed">35959897</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Valentini P, De Rose C, et al. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J Clin Med. 2022;11:4363. doi: 10.3390/jcm11154363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154363</ArticleId><ArticleId IdType="pmc">PMC9369242</ArticleId><ArticleId IdType="pubmed">35955979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruenjaiman V, Sodsai P, Kueanjinda P, et al. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery. J Microbiol Immunol Infect. 2022;55(6Pt 1):993&#x2013;1004. doi: 10.1016/j.jmii.2022.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.09.001</ArticleId><ArticleId IdType="pmc">PMC9519362</ArticleId><ArticleId IdType="pubmed">36220753</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandori WJ, Padgett LE, Alimadadi A, et al. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9(+) monocytes associated with COVID-19 hospitalization. J Leukoc Biol. 2022;112:1053&#x2013;1063. doi: 10.1002/jlb.4cova0122-076r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.4cova0122-076r</ArticleId><ArticleId IdType="pmc">PMC9350203</ArticleId><ArticleId IdType="pubmed">35866369</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, Neves PFMD, Lima SS, et al. Cytokine profiles associated with acute COVID-19 and Long COVID-19 syndrome. Front Cell Infect Microbiol. 2022;12 doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy. 2022;77:1288&#x2013;1291. doi: 10.1111/all.15188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi H, Zhou K, Shen L, et al. The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: a longitudinal cohort study. Int Immunopharmacol. 2022;110 doi: 10.1016/j.intimp.2022.109019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109019</ArticleId><ArticleId IdType="pmc">PMC9257193</ArticleId><ArticleId IdType="pubmed">35816945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Alcaide P, Asselbergs FW, et al. Long COVID and the cardiovascular system &#x2013; elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint scientific statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial &amp; Pericardial Diseases. Cardiovasc Res. 2023;119:336&#x2013;356. doi: 10.1093/cvr/cvac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisareva E, Badiou S, Mihalovi&#x10d;ov&#xe1; L, et al. Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J Med Virol. 2023;95:e28209. doi: 10.1002/jmv.28209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28209</ArticleId><ArticleId IdType="pmc">PMC9874393</ArticleId><ArticleId IdType="pubmed">36226380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12 doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Wang Q, Wang Y, et al. Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front Immunol. 2021;12 doi: 10.3389/fimmu.2021.791348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.791348</ArticleId><ArticleId IdType="pmc">PMC8720853</ArticleId><ArticleId IdType="pubmed">34987516</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Iorio M, Cook CE, Vanni KMM, et al. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study. Semin Arthritis Rheum. 2022;55 doi: 10.1016/j.semarthrit.2022.152025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152025</ArticleId><ArticleId IdType="pmc">PMC9116968</ArticleId><ArticleId IdType="pubmed">35617780</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ. Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms. Clin Infect Dis. 2022;74:2083&#x2013;2084. doi: 10.1093/cid/ciab890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab890</ArticleId><ArticleId IdType="pmc">PMC9187313</ArticleId><ArticleId IdType="pubmed">34617982</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody R, Sonda S, Johnston FH, et al. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.945021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.945021</ArticleId><ArticleId IdType="pmc">PMC9403331</ArticleId><ArticleId IdType="pubmed">36032086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603:587&#x2013;598. doi: 10.1038/s41586-022-04447-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Wijst MGP, Vazquez SE, Hartoularos GC, et al. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021;13:eabh2624. doi: 10.1126/scitranslmed.abh2624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abh2624</ArticleId><ArticleId IdType="pmc">PMC8601717</ArticleId><ArticleId IdType="pubmed">34429372</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Gervais A, Le Voyer T, et al. Autoantibodies neutralizing type I IFNs are present in &#x223c;4% of uninfected individuals over 70 years old and account for &#x223c;20% of COVID-19 deaths. Sci Immunol. 2021;6:eabl4340. doi: 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Mitchell A, Wang CY, et al. Low prevalence of interferon &#x3b1; autoantibodies in people experiencing symptoms of post-coronavirus disease 2019 (COVID-19) conditions, or long COVID. J Infect Dis. 2023;227:246&#x2013;250. doi: 10.1093/infdis/jiac372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac372</ArticleId><ArticleId IdType="pmc">PMC9494362</ArticleId><ArticleId IdType="pubmed">36089700</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021;12 doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarjour NN, Masopust D, Jameson SC. T cell memory: understanding COVID-19. Immunity. 2021;54:14&#x2013;18. doi: 10.1016/j.immuni.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7749639</ArticleId><ArticleId IdType="pubmed">33406391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasson SC, Gordon CL, Christo SN, Klenerman P, Mackay LK. Local heroes or villains: tissue-resident memory T cells in human health and disease. Cell Mol Immunol. 2020;17:113&#x2013;122. doi: 10.1038/s41423-019-0359-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0359-1</ArticleId><ArticleId IdType="pmc">PMC7000672</ArticleId><ArticleId IdType="pubmed">31969685</ArticleId></ArticleIdList></Reference><Reference><Citation>Goplen NP, Wu Y, Son YM, et al. Tissue-resident CD8(+) T cells drive age-associated chronic lung sequelae after viral pneumonia. Sci Immunol. 2020;5:eabc4557. doi: 10.1126/sciimmunol.abc4557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc4557</ArticleId><ArticleId IdType="pmc">PMC7970412</ArticleId><ArticleId IdType="pubmed">33158975</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55:542&#x2013;556.e5. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R, Campos MM, Palhinha L, et al. Persisting platelet activation and hyperactivity in COVID-19 survivors. Circ Res. 2022;131:944&#x2013;947. doi: 10.1161/circresaha.122.321659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C, et al. Serum metabolic profile in patients with Long-COVID (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021;8 doi: 10.3389/fmed.2021.714426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger BR, Arron HE, Kalka-Moll WM, Seidel D. The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19. Front Cardiovasc Med. 2022;9 doi: 10.3389/fcvm.2022.1007636.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1007636</ArticleId><ArticleId IdType="pmc">PMC9592739</ArticleId><ArticleId IdType="pubmed">36304538</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M. Long COVID patients travel abroad for expensive and experimental "blood washing". BMJ. 2022;378:o1671. doi: 10.1136/bmj.o1671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1671</ArticleId><ArticleId IdType="pubmed">35820689</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ven D, Bulu&#x15f; AD. Clinical and laboratory predictors of Long-COVID in children: a single center retrospective study. Eur Rev Med Pharmacol Sci. 2022;26:7695&#x2013;7704. doi: 10.26355/eurrev_202210_30046.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202210_30046</ArticleId><ArticleId IdType="pubmed">36314341</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra IL, Mosella M, et al. Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10:812. doi: 10.3390/biomedicines10040812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040812</ArticleId><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Satapathy AK, Bahinipati P. Delayed catastrophic thrombotic events in post-acute COVID-19. Thromb Res. 2022;220:60&#x2013;64. doi: 10.1016/j.thromres.2022.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.10.004</ArticleId><ArticleId IdType="pmc">PMC9550280</ArticleId><ArticleId IdType="pubmed">36270117</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrelli MP, Buora A, Frigatti P. The long haul COVID-19 arterial thrombosis. Thromb Res. 2022;217:73&#x2013;75. doi: 10.1016/j.thromres.2022.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.07.008</ArticleId><ArticleId IdType="pmc">PMC9334001</ArticleId><ArticleId IdType="pubmed">35908383</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, Schulze A, Evers G, et al. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozonoff A, Schaenman J, Jayavelu ND, et al. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study. EBioMedicine. 2022;83 doi: 10.1016/j.ebiom.2022.104208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104208</ArticleId><ArticleId IdType="pmc">PMC9359694</ArticleId><ArticleId IdType="pubmed">35952496</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaskamp L, Roubal C, Uddin S, et al. Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. 2022;11:2376. doi: 10.3390/cells11152376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152376</ArticleId><ArticleId IdType="pmc">PMC9367589</ArticleId><ArticleId IdType="pubmed">35954219</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Gennaro L, De Rose C, et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to Long COVID. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro L, Valentini P, Sorrentino S, et al. Extended coagulation profile of children with long COVID: a prospective study. Sci Rep. 2022;12:18392. doi: 10.1038/s41598-022-23168-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23168-y</ArticleId><ArticleId IdType="pmc">PMC9626616</ArticleId><ArticleId IdType="pubmed">36319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, Knauer MJ, Nicholson M, et al. Elevated vascular transformation blood biomarkers in long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med. 2022;28:122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Ward SE, Townsend L, et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J Thromb Haemost. 2022;20:2429&#x2013;2438. doi: 10.1111/jth.15830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, Trimarco V, Mone P, et al. Combining L-arginine with vitamin C improves long-COVID symptoms: the LINCOLN Survey. Pharmacol Res. 2022;183 doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G, Coppola A, Izzo R, et al. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021;40 doi: 10.1016/j.eclinm.2021.101125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Mone P, Trimarco B, Santulli G. Targeting endothelial dysfunction and oxidative stress in long-COVID. Pharmacol Res. 2022;184 doi: 10.1016/j.phrs.2022.106451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106451</ArticleId><ArticleId IdType="pmc">PMC9467917</ArticleId><ArticleId IdType="pubmed">36108875</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Shaik R, et al. Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults. Front Neurol. 2022;13 doi: 10.3389/fneur.2022.1012668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Schuepbach R, et al. Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 COVID-19 autopsies. Front Med. 2022;9 doi: 10.3389/fmed.2022.778489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.778489</ArticleId><ArticleId IdType="pmc">PMC8865372</ArticleId><ArticleId IdType="pubmed">35223894</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D, Lim JCT, Ferna&#xed;ndez SB, et al. Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.939989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939989</ArticleId><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hempel S, Chambers D, Bagnall AM, Forbes C. Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: a systematic scoping review of multiple predictor studies. Psychol Med. 2008;38:915&#x2013;926. doi: 10.1017/s0033291707001602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291707001602</ArticleId><ArticleId IdType="pubmed">17892624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi A. COVID-19 and mitochondrial non-coding RNAs: new insights from published data. Front Physiol. 2022;12 doi: 10.3389/fphys.2021.805005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.805005</ArticleId><ArticleId IdType="pmc">PMC8856670</ArticleId><ArticleId IdType="pubmed">35185603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross SM. Long COVID and mitochondrial dysfunction. Holist Nurs Pract. 2023;37:51&#x2013;53. doi: 10.1097/hnp.0000000000000566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/hnp.0000000000000566</ArticleId><ArticleId IdType="pubmed">36378091</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B, Silverstein A, Flores M, et al. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples. Sci Rep. 2021;11:3. doi: 10.1038/s41598-020-79552-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79552-z</ArticleId><ArticleId IdType="pmc">PMC7794290</ArticleId><ArticleId IdType="pubmed">33420163</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa TJ, Potje SR, Fraga-Silva TFC, et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vascul Pharmacol. 2022;142 doi: 10.1016/j.vph.2021.106946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106946</ArticleId><ArticleId IdType="pmc">PMC8612754</ArticleId><ArticleId IdType="pubmed">34838735</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz KJG, Benitez-Trinidad AB, Covantes-Rosales CE, et al. Loss of mitochondrial membrane potential (&#x394;&#x3a8;(m)) in leucocytes as post-COVID-19 sequelae. J Leukoc Biol. 2022;112:23&#x2013;29. doi: 10.1002/jlb.3ma0322-279rrr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.3ma0322-279rrr</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, Franzini M, Valdenassi L, et al. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy &#x2013; preliminary results on 100 patients. Eur Rev Med Pharmacol Sci. 2021;25:5871&#x2013;5875. doi: 10.26355/eurrev_202109_26809.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202109_26809</ArticleId><ArticleId IdType="pubmed">34604980</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, Nemkov T, de Boer E, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X, Ismail NI, Rahman A, et al. Long COVID-19 and the heart: is cardiac mitochondria the missing link? Antioxid Redox Signal. 2023;38:599&#x2013;618. doi: 10.1089/ars.2022.0126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2022.0126</ArticleId><ArticleId IdType="pmc">PMC10025846</ArticleId><ArticleId IdType="pubmed">36053670</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce 'Brain Fog' and results in behavioral changes that favor viral survival. Med Sci Monit. 2021;27 doi: 10.12659/msm.930886.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.930886</ArticleId><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Lau RI, Liu Q, Chan FKL, Ng SC. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance. Gut. 2023;72:1230&#x2013;1232. doi: 10.1136/gutjnl-2022-328319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-328319</ArticleId><ArticleId IdType="pubmed">35940857</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Su Q, Zhang F, et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat Commun. 2022;13:6806. doi: 10.1038/s41467-022-34535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wais T, Hasan M, Rai V, Agrawal DK. Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics. Expert Rev Clin Immunol. 2022;18:947&#x2013;960. doi: 10.1080/1744666x.2022.2105697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666x.2022.2105697</ArticleId><ArticleId IdType="pmc">PMC9388545</ArticleId><ArticleId IdType="pubmed">35868344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Li X, Huang L, et al. Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study. EClinicalMedicine. 2022;54 doi: 10.1016/j.eclinm.2022.101668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101668</ArticleId><ArticleId IdType="pmc">PMC9514976</ArticleId><ArticleId IdType="pubmed">36188433</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P, Luppi F, Rebora P, et al. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. Respir Res. 2022;23:65. doi: 10.1186/s12931-022-01994-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01994-y</ArticleId><ArticleId IdType="pmc">PMC8934910</ArticleId><ArticleId IdType="pubmed">35313890</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsi A, Caroli A, Bonaffini PA, et al. Structural and functional pulmonary assessment in severe COVID-19 survivors at 12 months after discharge. Tomography. 2022;8:2588&#x2013;2603. doi: 10.3390/tomography8050216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tomography8050216</ArticleId><ArticleId IdType="pmc">PMC9611724</ArticleId><ArticleId IdType="pubmed">36287815</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda J, Oriol I, Feria L, et al. Persistent COVID-19 symptoms 1 year after hospital discharge: a prospective multicenter study. PLoS One. 2022;17 doi: 10.1371/journal.pone.0275615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275615</ArticleId><ArticleId IdType="pmc">PMC9550043</ArticleId><ArticleId IdType="pubmed">36215250</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. 18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe9;lez M, Falcon&#xed; Paez A, Nicolalde B, et al. Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan. Eur Neuropsychopharmacol. 2022;61:91&#x2013;93. doi: 10.1016/j.euroneuro.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.06.010</ArticleId><ArticleId IdType="pmc">PMC9259455</ArticleId><ArticleId IdType="pubmed">35870344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Sanduzzi Zamparelli S, Mosella M, et al. Clinical assessment of endothelial function in convalescent COVID-19 patients: a meta-analysis with meta-regressions. Ann Med. 2022;54:3234&#x2013;3249. doi: 10.1080/07853890.2022.2136403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2136403</ArticleId><ArticleId IdType="pmc">PMC9673781</ArticleId><ArticleId IdType="pubmed">36382632</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C, Terlizzi M, Maglio A, et al. Activation of the AIM2 receptor in circulating cells of post-COVID-19 patients with signs of lung fibrosis is associated with the release of IL-1&#x3b1;, IFN-&#x3b1; and TGF-&#x3b2;. Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.934264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.934264</ArticleId><ArticleId IdType="pmc">PMC9277546</ArticleId><ArticleId IdType="pubmed">35844548</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova O, Lutokhina Y, Kogan E, et al. Chronic biopsy proven post-COVID myoendocarditis with SARS-Cov-2 persistence and high level of antiheart antibodies. Clin Cardiol. 2022;45:952&#x2013;959. doi: 10.1002/clc.23886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23886</ArticleId><ArticleId IdType="pmc">PMC9349976</ArticleId><ArticleId IdType="pubmed">35855554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;1889. doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MO, Banerjee A. Long COVID and cardiovascular disease: a learning health system approach. Nat Rev Cardiol. 2022;19:287&#x2013;288. doi: 10.1038/s41569-022-00697-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-022-00697-7</ArticleId><ArticleId IdType="pmc">PMC8943785</ArticleId><ArticleId IdType="pubmed">35332308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I, Lambadiari V, Mitrakou A, et al. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection. Eur J Heart Fail. 2022;24:727&#x2013;729. doi: 10.1002/ejhf.2451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2451</ArticleId><ArticleId IdType="pmc">PMC9087421</ArticleId><ArticleId IdType="pubmed">35138689</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla M, El-Arabey AA, Gai Z. Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome. J Med Virol. 2023;95:e28128. doi: 10.1002/jmv.28128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28128</ArticleId><ArticleId IdType="pmc">PMC9539041</ArticleId><ArticleId IdType="pubmed">36068170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul CB, Grimsmo J, Mecinaj A, et al. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19. J Am Heart Assoc. 2022;11 doi: 10.1161/JAHA.121.023473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.023473</ArticleId><ArticleId IdType="pmc">PMC9238505</ArticleId><ArticleId IdType="pubmed">35048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ECY, Tyler RE, Johnson D, et al. High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples. J Mol Cell Cardiol. 2022;170:121&#x2013;123. doi: 10.1016/j.yjmcc.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2022.06.006</ArticleId><ArticleId IdType="pmc">PMC9233549</ArticleId><ArticleId IdType="pubmed">35764120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021;32:2851&#x2013;2862. doi: 10.1681/asn.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang KC, Imig JD, Kalantar-Zadeh K, Gupta A. Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis. Curr Opin Nephrol Hypertens. 2022;31:36&#x2013;46. doi: 10.1097/mnh.0000000000000750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mnh.0000000000000750</ArticleId><ArticleId IdType="pubmed">34846312</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J, Reimer KC, Nagai JS, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29:217&#x2013;231.e8. doi: 10.1016/j.stem.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran CS, Kopp JB. RAGE pathway activation and function in chronic kidney disease and COVID-19. Front Med. 2022;9 doi: 10.3389/fmed.2022.970423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.970423</ArticleId><ArticleId IdType="pmc">PMC9395689</ArticleId><ArticleId IdType="pubmed">36017003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. 2022;132 doi: 10.1172/jci161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M, Babicki M, Kapusta J, et al. Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID registry of the PoLoCOV study. Viruses. 2022;14:1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13 doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;ufer C, Schreiber CS, Hartke AS, et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022;79 doi: 10.1016/j.ebiom.2022.103999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103999</ArticleId><ArticleId IdType="pmc">PMC9013202</ArticleId><ArticleId IdType="pubmed">35439679</ArticleId></ArticleIdList></Reference><Reference><Citation>Besteher B, Machnik M, Troll M, et al. Larger gray matter volumes in neuropsychiatric long-COVID syndrome. Psychiatry Res. 2022;317 doi: 10.1016/j.psychres.2022.114836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114836</ArticleId><ArticleId IdType="pmc">PMC9444315</ArticleId><ArticleId IdType="pubmed">36087363</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehringer F, Bruyere A, Doyen M, et al. Brain (18)F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. 2023;50:1084&#x2013;1089. doi: 10.1007/s00259-022-06013-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-06013-2</ArticleId><ArticleId IdType="pmc">PMC9628394</ArticleId><ArticleId IdType="pubmed">36322190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocciolillo F, Di Giuda D, Morello R, De Rose C, Valentini P, Buonsenso D. Orbito-frontal cortex hypometabolism in children with post-COVID condition (long COVID): a preliminary experience. Pediatr Infect Dis J. 2022;41:663&#x2013;665. doi: 10.1097/inf.0000000000003578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/inf.0000000000003578</ArticleId><ArticleId IdType="pmc">PMC9281418</ArticleId><ArticleId IdType="pubmed">35839175</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A, Barthel H, Tolboom N, et al. 2-[(18)F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee. Eur J Nucl Med Mol Imaging. 2022;49:3599&#x2013;3606. doi: 10.1007/s00259-022-05913-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05913-7</ArticleId><ArticleId IdType="pmc">PMC9286958</ArticleId><ArticleId IdType="pubmed">35840817</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573&#x2013;580. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020;395:e109. doi: 10.1016/s0140-6736(20)31282-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)31282-4</ArticleId><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri VP, Foschini MP, Lazzarotto T, et al. Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases. Brain Pathol. 2021;31:205&#x2013;210. doi: 10.1111/bpa.12901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12901</ArticleId><ArticleId IdType="pmc">PMC7536900</ArticleId><ArticleId IdType="pubmed">33002281</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R, Mayilsamy K, McGill AR, et al. SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk. Mol Ther Methods Clin Dev. 2022;27:217&#x2013;229. doi: 10.1016/j.omtm.2022.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.09.007</ArticleId><ArticleId IdType="pmc">PMC9508696</ArticleId><ArticleId IdType="pubmed">36187720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki SN, Kantonen J, Kaivola K, et al. APOE &#x3b5;4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol Commun. 2021;9:199. doi: 10.1186/s40478-021-01302-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01302-7</ArticleId><ArticleId IdType="pmc">PMC8696243</ArticleId><ArticleId IdType="pubmed">34949230</ArticleId></ArticleIdList></Reference><Reference><Citation>Golzari-Sorkheh M, Weaver DF, Reed MA. COVID-19 as a risk factor for Alzheimer's disease. J Alzheimers Dis. 2023;91:1&#x2013;23. doi: 10.3233/jad-220800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-220800</ArticleId><ArticleId IdType="pubmed">36314211</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G, Tetz V. Prion-like domains in spike protein of SARS-CoV-2 differ across its variants and enable changes in affinity to ACE2. Microorganisms. 2022;10:280. doi: 10.3390/microorganisms10020280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10020280</ArticleId><ArticleId IdType="pmc">PMC8878784</ArticleId><ArticleId IdType="pubmed">35208734</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Jaber VR, Lukiw WJ. SARS-CoV-2, long COVID, prion disease and neurodegeneration. Front Neurosci. 2022;16 doi: 10.3389/fnins.2022.1002770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.1002770</ArticleId><ArticleId IdType="pmc">PMC9551214</ArticleId><ArticleId IdType="pubmed">36238082</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora D, Nolano M, Acanfora C, et al. Impaired vagal activity in long-COVID-19 patients. Viruses. 2022;14:1035. doi: 10.3390/v14051035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051035</ArticleId><ArticleId IdType="pmc">PMC9147759</ArticleId><ArticleId IdType="pubmed">35632776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasnier M, Choucha W, Radiguer F, et al. Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study. J Neurol Neurosurg Psychiatry. 2022 doi: 10.1136/jnnp-2021-328516. : jnnp-2021-328516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-328516</ArticleId><ArticleId IdType="pubmed">35953265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner M, Liu J, Counsell N, et al. The COVANOS trial &#x2013; insight into post-COVID olfactory dysfunction and the role of smell training. Rhinology. 2022;60:188&#x2013;199. doi: 10.4193/Rhin21.470.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.470</ArticleId><ArticleId IdType="pubmed">35901492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto-Urata M, Urata S, Kagoya R, et al. Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit. Sci Rep. 2022;12:5728. doi: 10.1038/s41598-022-09731-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09731-7</ArticleId><ArticleId IdType="pmc">PMC8987081</ArticleId><ArticleId IdType="pubmed">35388072</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JW, Wang X, Xu RH. Revealing the mystery of persistent smell loss in long COVID patients. Int J Biol Sci. 2022;18:4795&#x2013;4808. doi: 10.7150/ijbs.73485.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.73485</ArticleId><ArticleId IdType="pmc">PMC9305264</ArticleId><ArticleId IdType="pubmed">35874953</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay JB, Brann DH, Abi Hachem R, et al. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci Transl Med. 2022;14:eadd0484. doi: 10.1126/scitranslmed.add0484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.add0484</ArticleId><ArticleId IdType="pmc">PMC10317309</ArticleId><ArticleId IdType="pubmed">36542694</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga-Paz I, Ferreira de Ara&#xfa;jo JL, Alves HJ, et al. Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: new clues to long-term cognitive disorders. Front Cell Infect Microbiol. 2022;12 doi: 10.3389/fcimb.2022.905757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.905757</ArticleId><ArticleId IdType="pmc">PMC9556632</ArticleId><ArticleId IdType="pubmed">36250059</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jesus JR, Galazzi RM, Lopes CA, J&#xfa;nior, Arruda MAZ. Trace element homeostasis in the neurological system after SARS-CoV-2 infection: insight into potential biochemical mechanisms. J Trace Elem Med Biol. 2022;71 doi: 10.1016/j.jtemb.2022.126964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2022.126964</ArticleId><ArticleId IdType="pmc">PMC8881805</ArticleId><ArticleId IdType="pubmed">35240553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Beuschlein F, Bornstein SR. Is there a role for the adrenal glands in long COVID? Nat Rev Endocrinol. 2022;18:451&#x2013;452. doi: 10.1038/s41574-022-00700-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00700-8</ArticleId><ArticleId IdType="pmc">PMC9150041</ArticleId><ArticleId IdType="pubmed">35637413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschbaum C. What to do now that hypocortisol appears to be a predominant sign of long COVID? Psychoneuroendocrinology. 2022;145 doi: 10.1016/j.psyneuen.2022.105919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2022.105919</ArticleId><ArticleId IdType="pmc">PMC9446679</ArticleId><ArticleId IdType="pubmed">36126384</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavropoulou MP, Tsokos GC, Chrousos GP, Sfikakis PP. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of long COVID. Clin Immunol. 2022;245 doi: 10.1016/j.clim.2022.109133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109133</ArticleId><ArticleId IdType="pmc">PMC9519365</ArticleId><ArticleId IdType="pubmed">36182048</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, et al. Distinguishing features of long COVID identified through immune profiling. medRxiv 2022. doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Evert K, Stadtm&#xfc;ller M, et al. COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol. 2022;10:13&#x2013;16. doi: 10.1016/s2213-8587(21)00291-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(21)00291-6</ArticleId><ArticleId IdType="pmc">PMC8601687</ArticleId><ArticleId IdType="pubmed">34801110</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Guijarro C, Torres-Macho J, et al. Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021;70:2917&#x2013;2921. doi: 10.2337/db21-0329.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0329</ArticleId><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonyek-Silva I, Cerqueira-Silva T, Nunes S, et al. Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms. Front Endocrinol. 2022;13 doi: 10.3389/fendo.2022.896378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.896378</ArticleId><ArticleId IdType="pmc">PMC9311489</ArticleId><ArticleId IdType="pubmed">35898449</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Anton MC. Persistence of new-onset diabetes in the post-acute phase of COVID-19. Int J Diabetes Dev Ctries. 2023;43:118&#x2013;119. doi: 10.1007/s13410-022-01119-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13410-022-01119-7</ArticleId><ArticleId IdType="pmc">PMC9302869</ArticleId><ArticleId IdType="pubmed">35892064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23:870&#x2013;874. doi: 10.1111/dom.14269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/s2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Shu T, Zhu R, Yang F, Zhang B, Lai X. The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan. J Clin Med. 2022;11:3094. doi: 10.3390/jcm11113094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11113094</ArticleId><ArticleId IdType="pmc">PMC9181214</ArticleId><ArticleId IdType="pubmed">35683480</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi AP, Muollo V, Dalla Valle Z, et al. The role of obesity, body composition, and nutrition in COVID-19 pandemia: a narrative review. Nutrients. 2022;14:3493. doi: 10.3390/nu14173493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14173493</ArticleId><ArticleId IdType="pmc">PMC9458228</ArticleId><ArticleId IdType="pubmed">36079751</ArticleId></ArticleIdList></Reference><Reference><Citation>Heubner L, Petrick PL, G&#xfc;ldner A, et al. Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome. Sci Rep. 2022;12:18418. doi: 10.1038/s41598-022-22107-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-22107-1</ArticleId><ArticleId IdType="pmc">PMC9626466</ArticleId><ArticleId IdType="pubmed">36319681</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosen SH, Jensen BO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection. 2022;50:1165&#x2013;1170. doi: 10.1007/s15010-022-01784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01784-0</ArticleId><ArticleId IdType="pmc">PMC8966865</ArticleId><ArticleId IdType="pubmed">35355237</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar IM, Weaver JS, Samet JD, Serhal AM, Mar WA, Taljanovic MS. Musculoskeletal manifestations of COVID-19: currently described clinical symptoms and multimodality imaging findings. Radiographics. 2022;42:1415&#x2013;1432. doi: 10.1148/rg.220036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.220036</ArticleId><ArticleId IdType="pmc">PMC9341171</ArticleId><ArticleId IdType="pubmed">35867593</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes-Ibarra M, Oliveira CLP, Orsso CE, Landi F, Marzetti E, Prado CM. The impact of long COVID-19 on muscle health. Clin Geriatr Med. 2022;38:545&#x2013;557. doi: 10.1016/j.cger.2022.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC8934728</ArticleId><ArticleId IdType="pubmed">35868672</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiesshoefer J, Friedrich J, Regmi B, et al. Diaphragm dysfunction as a potential determinant of dyspnea on exertion in patients 1 year after COVID-19-related ARDS. Respir Res. 2022;23:187. doi: 10.1186/s12931-022-02100-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02100-y</ArticleId><ArticleId IdType="pmc">PMC9284093</ArticleId><ArticleId IdType="pubmed">35841032</ArticleId></ArticleIdList></Reference><Reference><Citation>Grund S, Bauer JM. Malnutrition and sarcopenia in COVID-19 survivors. Clin Geriatr Med. 2022;38:559&#x2013;564. doi: 10.1016/j.cger.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9021037</ArticleId><ArticleId IdType="pubmed">35868673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Liu XZ, Tian Q, et al. Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-months recovery of COVID-19. Front Cell Dev Biol. 2022;10 doi: 10.3389/fcell.2022.1001558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.1001558</ArticleId><ArticleId IdType="pmc">PMC9574079</ArticleId><ArticleId IdType="pubmed">36263014</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Li W, Wang T, et al. Accelerated biological aging in COVID-19 patients. Nat Commun. 2022;13:2135. doi: 10.1038/s41467-022-29801-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29801-8</ArticleId><ArticleId IdType="pmc">PMC9018863</ArticleId><ArticleId IdType="pubmed">35440567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Arendt-Nielsen L, D&#xed;az-Gil G, et al. Genetic association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) polymorphisms with post-COVID symptoms in previously hospitalized COVID-19 survivors. Genes. 2022;13:1935. doi: 10.3390/genes13111935.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13111935</ArticleId><ArticleId IdType="pmc">PMC9690177</ArticleId><ArticleId IdType="pubmed">36360172</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo YS, Luo L, Li W, et al. Evaluation of a functional single nucleotide polymorphism of the SARS-CoV-2 receptor ACE2 that is potentially involved in long COVID. Front Genet. 2022;13 doi: 10.3389/fgene.2022.931562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.931562</ArticleId><ArticleId IdType="pmc">PMC9340221</ArticleId><ArticleId IdType="pubmed">35923692</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J, Graninger M, Lettenmaier L, et al. Association between Epstein-Barr-Virus reactivation and development of long-COVID fatigue. Allergy. 2023;78:297&#x2013;299. doi: 10.1111/all.15471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15471</ArticleId><ArticleId IdType="pmc">PMC9538037</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>